Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimise Treatment Duration in Genotype 1 Non-Cirrhotic Treatment-Naïve Patients with Chronic Hepatitis C Virus
May 1, 2018, 00:00
10.1016/j.jval.2018.04.043
https://www.valueinhealthjournal.com/article/S1098-3015(18)30343-7/fulltext
Title :
Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimise Treatment Duration in Genotype 1 Non-Cirrhotic Treatment-Naïve Patients with Chronic Hepatitis C Virus
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30343-7&doi=10.1016/j.jval.2018.04.043
First page :
Section Title :
Open access? :
No
Section Order :
1395